The Board of Directors of Maccura Biotechnology Co.Ltd has authorized a buyback plan on February 5, 2024.
Maccura Biotechnology Co.Ltd
Equities
300463
CNE1000020H3
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.35 CNY | -0.60% | -2.98% | -11.41% |
25/04 | Maccura Biotechnology Co.Ltd Proposes Final Cash Dividend for the Year 2023 | CI |
24/04 | Maccura Biotechnology Co.Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.41% | 1.13B | |
-1.52% | 8.37B | |
+10.68% | 5.84B | |
+26.94% | 5.4B | |
-5.09% | 4.37B | |
-52.54% | 3.23B | |
+14.18% | 2.8B | |
+32.50% | 2.26B | |
-6.47% | 2.22B | |
-1.69% | 1.87B |
- Stock Market
- Equities
- 300463 Stock
- News Maccura Biotechnology Co.Ltd
- Maccura Biotechnology Co.Ltd authorizes a Buyback Plan.